scholarly article | Q13442814 |
P356 | DOI | 10.1111/1751-2980.12064 |
P698 | PubMed publication ID | 23615075 |
P2093 | author name string | Dong Chen | |
Xiao Yan Wang | |||
An Bin Hu | |||
Xiang Song Zhang | |||
Zhi Feng Chen | |||
P2860 | cites work | Management of hepatocellular carcinoma: An update | Q27860530 |
Clinical applications of positron emission tomography in hepatic tumors | Q39734745 | ||
The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma. | Q39823357 | ||
Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. | Q40813713 | ||
Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography | Q44311389 | ||
18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma | Q46775794 | ||
Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. | Q46845089 | ||
Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma? | Q53364512 | ||
Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience. | Q53445078 | ||
The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. | Q53521000 | ||
What Is the Best Time to Evaluate Treatment Response after Radiofrequency Ablation of Hepatocellular Carcinoma Using Contrast-Enhanced Sonography? | Q57763672 | ||
P433 | issue | 8 | |
P921 | main subject | hepatectomy | Q1514021 |
recurrent hepatocellular carcinoma | Q19000463 | ||
Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 | ||
P304 | page(s) | 433-438 | |
P577 | publication date | 2013-08-01 | |
P1433 | published in | Journal of Digestive Diseases | Q15757872 |
P1476 | title | Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound. | |
P478 | volume | 14 |
Q58706794 | 18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma |
Q89701966 | Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection |
Q89282387 | Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma |
Q90136092 | Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects |
Q26830236 | The Role of PET Imaging Before, During, and After Percutaneous Hepatic and Pulmonary Tumor Ablation |
Search more.